EMA Panel Backs Two Octocog Alfa Products for Hemophilia A EMA Panel Backs Two Octocog Alfa Products for Hemophilia A

Iblias and Kovaltry from Bayer Pharma AG are indicated for treatment and prevention of bleeding in patients with hemophilia A. International Approvals
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Hematology-Oncology News Alert Source Type: news